Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.680
-0.410 (-10.02%)
At close: May 13, 2026, 4:00 PM EDT
3.820
+0.140 (3.80%)
After-hours: May 13, 2026, 7:11 PM EDT
Ironwood Pharmaceuticals Employees
Ironwood Pharmaceuticals had 100 employees as of December 31, 2025. The number of employees decreased by 153 or -60.47% compared to the previous year.
Employees
100
Change (1Y)
-153
Growth (1Y)
-60.47%
Revenue / Employee
$3,615,140
Profits / Employee
$1,021,760
Market Cap
605.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 100 | -153 | -60.47% |
| Dec 31, 2024 | 253 | -14 | -5.24% |
| Dec 31, 2023 | 267 | 48 | 21.92% |
| Dec 31, 2022 | 219 | 0 | - |
| Dec 31, 2021 | 219 | -13 | -5.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| Emergent BioSolutions | 900 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Kamada | 462 |
| Xeris Biopharma Holdings | 435 |
| Esperion Therapeutics | 294 |
IRWD News
- 6 days ago - Ironwood Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance - Business Wire
- 9 days ago - Ironwood presents new findings at DDW 2026 from survey treatment of SBS - TheFly
- 9 days ago - Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS) - Business Wire
- 13 days ago - Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call - Business Wire
- 20 days ago - Ironwood to present data from Landmark survey on SBS - TheFly
- 20 days ago - Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026 - Business Wire
- 2 months ago - Ironwood Pharmaceuticals Transcript: The Citizens Life Sciences Conference 2026 - Transcripts